Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure

MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.

Danaher to buy antibody supplier Abcam for $5.7B

Dive Brief: Danaher plans to buy Cambridge, England-based Abcam for about $5.7 billion in cash, the companies announced on Monday. The acquisition would bring together

August 28, 2023

MarketingRx roundup: Bristol Myers enlists Ted Danson for psoriasis campaign; Regeneron debuts Eylea HD effort

Bristol Myers Squibb adds star power to its psoriasis advertising. The drugmaker is working with actor and psoriasis sufferer Ted Danson to its Sotyktu marketing

March 20, 2024

Sanofi signs agreement to acquire Inhibrx for $1.7bn

Share this article The Inhibrx acquisition is expected to bolster Sanofi’s portfolio in rare diseases and oncology. Credit: nitpicker / Shutterstock.com. Sanofi has signed an

January 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.